10.41
price down icon5.28%   -0.58
after-market Dopo l'orario di chiusura: 10.46 0.05 +0.48%
loading
Precedente Chiudi:
$10.99
Aprire:
$10.85
Volume 24 ore:
34,970
Relative Volume:
0.28
Capitalizzazione di mercato:
$154.15M
Reddito:
$54,000
Utile/perdita netta:
$-210.26M
Rapporto P/E:
-13.18
EPS:
-0.79
Flusso di cassa netto:
$-159.01M
1 W Prestazione:
+9.35%
1M Prestazione:
+8.61%
6M Prestazione:
-13.97%
1 anno Prestazione:
-67.67%
Intervallo 1D:
Value
$10.26
$11.16
Intervallo di 1 settimana:
Value
$9.24
$11.16
Portata 52W:
Value
$7.65
$34.90

Lyell Immunopharma Inc Stock (LYEL) Company Profile

Name
Nome
Lyell Immunopharma Inc
Name
Telefono
650 695-0677
Name
Indirizzo
201 HASKINS WAY, SOUTH SAN FRANCISCO
Name
Dipendente
300
Name
Cinguettio
Name
Prossima data di guadagno
2025-03-12
Name
Ultimi documenti SEC
Name
LYEL's Discussions on Twitter

Confronta LYEL con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
LYEL
Lyell Immunopharma Inc
10.41 162.74M 54,000 -210.26M -159.01M -0.79
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Lyell Immunopharma Inc Stock (LYEL) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-10-30 Downgrade BofA Securities Buy → Underperform
2024-06-27 Downgrade H.C. Wainwright Buy → Neutral
2023-08-28 Downgrade JP Morgan Overweight → Neutral
2022-11-14 Downgrade Morgan Stanley Overweight → Equal-Weight
2022-11-11 Downgrade Goldman Buy → Neutral
2022-10-17 Iniziato H.C. Wainwright Buy
2021-07-12 Iniziato BofA Securities Buy
2021-07-12 Iniziato Goldman Buy
2021-07-12 Iniziato JP Morgan Overweight
2021-07-12 Iniziato Morgan Stanley Overweight
Mostra tutto

Lyell Immunopharma Inc Borsa (LYEL) Ultime notizie

pulisher
Jul 24, 2025

What makes Lyell Immunopharma Inc. stock attractive to long term investorsFree Stock Movement Tracking - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 23, 2025

What analysts say about Lyell Immunopharma Inc. stockLightning-fast capital gains - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

What drives Lyell Immunopharma Inc. stock priceFastest return on investment - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Positive week for Lyell Immunopharma, Inc. (NASDAQ:LYEL) institutional investors who lost 70% over the past year - simplywall.st

Jul 23, 2025
pulisher
Jul 22, 2025

Lyell Immunopharma Inc. Stock Analysis and ForecastHigh-yield investments - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Is Lyell Immunopharma Inc. a good long term investmentFree Predictions - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Lyell Immunopharma's LYL314: A High-Risk, High-Reward Catalyst in the CAR T-Cell Space - AInvest

Jul 22, 2025
pulisher
Jul 22, 2025

Lyell: 'Hold' Rating Based On Phase 3 LYL314 LBCL Treatment Program Advancement (LYEL) - Seeking Alpha

Jul 22, 2025
pulisher
Jul 20, 2025

Lyell Immunopharma registers 625,000 shares for resale - MSN

Jul 20, 2025
pulisher
Jul 16, 2025

why lyell immunopharma inc. stock attracts strong analyst attentionStable Stocks With High Yield - Newser

Jul 16, 2025
pulisher
Jul 16, 2025

Lyell Immunopharma (NASDAQ:LYEL) Stock Price Down 5.9% – What’s Next? - Defense World

Jul 16, 2025
pulisher
Jul 15, 2025

Why Lyell Immunopharma Inc. stock attracts strong analyst attentionShort Term High Return Strategy - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Lyell Immunopharma Inc. stock price move sharplyPredictable High Return Trades - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Lyell Immunopharma Inc. stock performs during market volatilityFree Stock Market Trend Analysis - Newser

Jul 15, 2025
pulisher
Jun 25, 2025

Lyell Immunopharma’s (LYEL) “Neutral” Rating Reiterated at HC Wainwright - Defense World

Jun 25, 2025
pulisher
Jun 24, 2025

Lyell Immunopharma (NASDAQ:LYEL) Trading 3.5% Higher – What’s Next? - Defense World

Jun 24, 2025
pulisher
Jun 23, 2025

Lyell Immunopharma to Participate in the H.C. Wainwright “HCW@Home” Series - GlobeNewswire

Jun 23, 2025
pulisher
Jun 18, 2025

Lyell reports new clinical data from trial of large B-cell lymphoma therapy - Yahoo Finance

Jun 18, 2025
pulisher
Jun 17, 2025

Lyell’s lymphoma therapy shows high response rate in trial - Investing.com

Jun 17, 2025
pulisher
Jun 17, 2025

Lyell’s lymphoma therapy shows high response rate in trial By Investing.com - Investing.com Nigeria

Jun 17, 2025
pulisher
Jun 17, 2025

Lyell Immunopharma Announces Promising CAR T-Cell Trial Data - TipRanks

Jun 17, 2025
pulisher
Jun 17, 2025

Lyell Immunopharma Says LYL314 Shows 'Robust' Responses in Large B-Cell Lymphoma Trial - marketscreener.com

Jun 17, 2025
pulisher
Jun 17, 2025

Lyell Immunopharma (LYEL) Releases Promising Results from LYL314 Trial | LYEL Stock News - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

Lyell Immunopharma Announces Positive Clinical Data From Phase 1/2 Trial Of Lyl314 For The Treatment Of Aggressive Large B-Cell Lymphoma - MarketScreener

Jun 17, 2025
pulisher
Jun 17, 2025

Lyell Immunopharma Announces Positive New Clinical Data - GlobeNewswire

Jun 17, 2025
pulisher
Jun 17, 2025

Lyell Immunopharma Stock Soars 23.11% Post Reverse Split - AInvest

Jun 17, 2025
pulisher
Jun 10, 2025

Lyell Immunopharma (LYEL) Strengthens Leadership Team with Key A - GuruFocus

Jun 10, 2025
pulisher
Jun 09, 2025

Lyell Immunopharma (LYEL) Announces Key Executive Appointments | LYEL Stock News - GuruFocus

Jun 09, 2025

Lyell Immunopharma Inc Azioni (LYEL) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Capitalizzazione:     |  Volume (24 ore):